Silence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA therapeutics, stands at a crucial juncture ...

Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

Image source: Prostock-studio / Adobe Frequency Therapeutics, an MIT spinout, is looking for new ways to reverse hearing loss. Not by equipping patients with hearing aids or implants, though.

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

Although there has been a rise in the popularity of fillers and injectables over recent years, many beauty enthusiasts are ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

A key metric may indicate the S&P 500's market's direction for the rest of 2025.

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Our earbuds combine real-time measurement and customized sound therapy in a single device,” CEO and founder Seungpyo Noh told ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...